Organovo Holdings, Inc. (ONVO)

[WinnerAlright]

The press release about the ExVive3D commercial release includes the following sentence:

"Initially, clients will be able to access the technology through Organovo's contract research services program."

The term "clients" seems to imply to me that there are already paying customers for these liver tissues. Does anybody have any educated guess or information about who the clients might be? I know ONVO has worked with companies such as Roche and Janssen R&D in the past (as well as NIH) but I am not aware of any information about a current paying client for these tissues. Anybody have any thoughts or information?

Also what evidence is there that companies actually want these tissues (other than Organovo information that the companies could save money by testing early drugs on these tissues)?